Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients

被引：3

作者：

Caillard, S

Leray, C

Kunz, K

Gachet, C

Offner, M

Wiesel, ML

Hannedouchte, T

Cazenave, JP

Moulin, B

机构：

[1] CHU Strasbourg, Nephrol Transplantat Dept, F-67000 Strasbourg, France

[2] INSERM, Unit U311, Strasbourg, France

[3] CHU Strasbourg, Biochem Lab, F-67000 Strasbourg, France

来源：

TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 08期

关键词：

D O I：

10.1016/S0041-1345(00)01886-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

引用

页码：2787 / 2788

页数：2

共 7 条

[1]

Effect of atorvastatin of the treatment of hypercholesterolemia after renal transplantation [J].

Alvarez, ML ;

Errasti, P ;

Gómez, G ;

Lavilla, FJ ;

García, N ;

Ballester, B ;

García, I ;

Purroy, A .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) :2328-2329

[2]

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: Are the statins mechanistically similar? [J].

Christians, U ;

Jacobsen, W ;

Floren, LC .

PHARMACOLOGY & THERAPEUTICS, 1998, 80 (01) :1-34

[3]

Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine [J].

Goldberg, R ;

Roth, D .

TRANSPLANTATION, 1996, 62 (11) :1559-1564

[4]

HAUSBERG M, 1999, AM SOC NEPHROLOGY, pA677

[5]

RISK-FACTORS FOR ACCELERATED ATHEROSCLEROSIS IN RENAL-TRANSPLANT RECIPIENTS [J].

KASISKE, BL .

AMERICAN JOURNAL OF MEDICINE, 1988, 84 (06) :985-992

[6]

PEDERSEN TR, 1994, LANCET, V344, P1383

[7]

HYPERTENSION AND ISCHEMIC-HEART-DISEASE IN RENAL-TRANSPLANT RECIPIENTS [J].

RAINE, AEG .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 :95-100

← 1 →